Opiate receptor binding sites in human brain

Subclasses of opiate receptor binding sites in human brain membranes were investigated by means of competitive binding techniques. The experimental data were analyzed by use of a computerized non-linear regression curve fitting program. mu-, delta-and chi-types of opiate binding were found in 5 different regions of the brain. A more extensive analysis of the regional distribution of subclasses of opiate binding sites was performed using a simple sequential inhibition technique. This method was shown to yield results which are comparable to those obtained by computer analysis of multiple tracer displacement curves. Chi-and mu-sites represented the major component of binding in most brain areas whereas delta-sites were fewer in number. The 3 types of binding showed different distribution patterns, suggesting that they are independent from each other. The distribution pattern observed in human brain resembled the one observed in rat brain, although chi-sites appear to represent a more important, and delta-sites appear to represent a less important, fraction of binding in human as compared to rat brain.

[1]  W. Martin.  Opioid antagonists. , 1967, Pharmacological reviews.

[2]  H. Kosterlitz,et al.  CHARACTERIZATION OF THE k‐SUBTYPE OF THE OPIATE RECEPTOR IN THE GUINEA‐PIG BRAIN , 1981 .

[3]  P. Cuatrecasas,et al.  Novel opiate binding sites selective for benzomorphan drugs , 1981 .

[4]  J. Volavka,et al.  Short-term hormonal effects of naloxone in man , 1980, Psychoneuroendocrinology.

[5]  A. Herz,et al.  A subclassification of κ-sites in human brain by use of dynorphin 1–17 , 1981, Neuropeptides.

[6]  A. Herz,et al.  Regional distribution of methionine-enkephalin- and beta-endorphin-like immunoreactivity in human brain and pituitary , 1979, Brain Research.

[7]  E. J. Simon,et al.  Opiate receptor heterogeneity in human brain regions , 1981, Brain Research.

[8]  A. Grossman,et al.  THE OPIOID CONTROL OF LH AND FSH RELEASE: EFFECTS OF A MET‐ENKEPHALIN ANALOGUE AND NALOXONE , 1981, Clinical endocrinology.

[9]  D. Jasinski,et al.  Assessment of the Abuse Potentiality of Morphinelike Drugs (Methods Used in Man) , 1977 .

[10]  John Hughes,et al.  Endogenous opioid peptides: multiple agonists and receptors , 1977, Nature.

[11]  A. Herz,et al.  Demonstration and distribution of an opiate binding site in rat brain with high affinity for ethylketocyclazocine and SKF 10,047. , 1981, Biochemical and biophysical research communications.

[12]  L. Hood,et al.  Dynorphin-(1-13), an extraordinarily potent opioid peptide. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[13]  A. Herz,et al.  Immunoreactive dynorphin in human brain and pituitary , 1982, Brain Research.

[14]  L. Hood,et al.  Porcine pituitary dynorphin: complete amino acid sequence of the biologically active heptadecapeptide. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[15]  J. Thompson,et al.  The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog. , 1976, The Journal of pharmacology and experimental therapeutics.

[16]  H. Emrich.  A possible role of opioid substances in depression. , 1982, Advances in biochemical psychopharmacology.

[17]  A. Herz,et al.  Discrimination of three opiate receptor binding sites with the use of a computerized curve-fitting technique. , 1982, Molecular pharmacology.

[18]  S. Tachibana,et al.  ISOLATION OF DYNORPHIN-LIKE PEPTIDE FROM GUT EXTRACT , 1981 .

[19]  D Rodbard,et al.  Ligand: a versatile computerized approach for characterization of ligand-binding systems. , 1980, Analytical biochemistry.

[20]  Emrich Hm.  A possible role of opioid substances in depression. , 1982 .

[21]  K. Alberti,et al.  HORMONAL AND METABOLIC RESPONSES TO AN ENKEPHALIN ANALOGUE IN NORMAL MAN , 1978, The Lancet.